Borrelia burgdorferi Not Confirmed in Human-Biting Amblyomma americanum Ticks from the Southeastern United States by Stromdahl, Ellen et al.
Borrelia burgdorferi Not Confirmed in Human-Biting Amblyomma
americanum Ticks from the Southeastern United States
Ellen Y. Stromdahl,a Robyn M. Nadolny,a,b Jennifer A. Gibbons,c,d Lisa D. Auckland,e Mary A. Vince,a Chad E. Elkins,a
Michael P. Murphy,a Graham J. Hickling,f Mark W. Eshoo,g Heather E. Carolan,g Chris D. Crowder,g Mark A. Pilgard,h Sarah A. Hamere
U.S. Army Public Health Command, Aberdeen Proving Ground, Maryland, USAa; Department of Biological Sciences, Old Dominion University, Norfolk, Virginia, USAb; U.S.
Army Edgewood Chemical and Biological Center, Aberdeen Proving Ground, Maryland, USAc; Science and Technology Corp., Hampton, Virginia, USAd; Department of
Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, USAe; Center for Wildlife Health, University of Tennessee Institute of Agriculture, Knoxville,
Tennessee, USAf; Ibis Biosciences, Carlsbad, California, USAg; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USAh
The predominant human-biting tick throughout the southeastern United States is Amblyomma americanum. Its ability to trans-
mit pathogens causing Lyme disease-like illnesses is a subject of ongoing controversy. Results of previous testing by the Depart-
ment of Defense Human Tick Test Kit Program and other laboratories indicated that it is highly unlikely that A. americanum
transmits any pathogen that causes Lyme disease. In contrast, a recent publication by Clark and colleagues (K. L. Clark, B. Ley-
det, and S. Hartman, Int. J. Med. Sci. 10:915–931, 2013) reported detection of Lyme group Borrelia in A. americanum using a
nested-flagellin-gene PCR. We evaluated this assay by using it and other assays to test 1,097 A. americanum ticks collected from
humans. Using the Clark assay, in most samples we observed nonspecific amplification and nonrepeatability of results on subse-
quent testing of samples. Lack of reaction specificity and repeatability is consistent with mispriming, likely due to high primer
concentrations and low annealing temperatures in this protocol. In six suspect-positive samples, Borrelia lonestari was identi-
fied by sequencing of an independent gene region; this is not a Lyme group spirochete and is not considered zoonotic. B. burg-
dorferi was weakly amplified from one pool using some assays, but not others, and attempts to sequence the amplicon of this
pool failed, as did attempts to amplify and sequence B. burgdorferi from the five individual samples comprising this pool. There-
fore, B. burgdorferi was not confirmed in any sample. Our results do not support the hypothesis that A. americanum ticks are a
vector for Lyme group Borrelia infections.
The vectors and etiologic agents of Lyme-like diseases in thesoutheastern United States are a subject of ongoing contro-
versy (1, 2). In the United States, most Lyme disease is caused by
infection with Borrelia burgdorferi sensu stricto, a bacterium that is
phylogenetically within the B. burgdorferi sensu lato “Lyme group”
of spirochetes vectored by hard ticks. The Lyme group also in-
cludes genospecies implicated as the etiologic agents of Lyme dis-
ease in other geographic regions, including B. garinii, B. afzelii, B.
spielmanii, and B. valaisiana in Europe. Additional Lyme group
genospecies continue to be described. In the United States, these
include B. americana, B. andersonii, and B. carolinensis, all of un-
known pathogenicity, and B. bissettii, which has been implicated
in cases of human illness (1). In contrast to the Lyme group, the
relapsing fever (RF) group spirochetes, many of which are vec-
tored by soft ticks, are a separate phylogenetic cluster that includes
agents associated with RF disease in humans. In the United States,
genospecies within the RF group include B. hermsii, B. turicatae,
and B. parkeri, vectored by soft ticks, and B. miyamotoi, B. davisii,
andB. lonestari, vectored by hard ticks.B. hermsii is the main cause
of tick-borne relapsing fever in the United States; B. turicatae and
B. parkeri have also been associated with human disease (3). B.
miyamotoi was recently implicated as a cause of human disease in
the United States (4), and the pathogenicity of B. davisii is un-
known. B. lonestari was provisionally implicated in a single case of
early Lyme disease-like illness (erythema migrans), but subse-
quent investigation has not established it as a human pathogen
(5–7).
The predominant human-biting tick throughout the Southeast
is Amblyomma americanum, accounting for over 90% of tick bites
in southeastern states (8, 9). Vector competency studies have con-
cluded repeatedly that B. burgdorferi is unlikely to be transmitted
by A. americanum (10–16), and a potent borreliacidal agent has
been identified in A. americanum saliva (17, 18). From 1997 to
2010, the Department of Defense (DOD) Human Tick Test Kit
Program (HTTKP), a tick identification and PCR testing service
provided by the U.S. Army Public Health Command (USAPHC)
for DOD personnel and dependents, tested 22,565 A. americanum
ticks (21,245 adults and nymphs removed from humans, and
1,320 field-collected larvae) for borrelial agents of Lyme-like dis-
eases using a series of nested- and real-time PCR assays. These
ticks include representation across the majority of the geographic
distribution of the species (8, 9).
HTTKP methods have evolved across the years in response to
changing diagnostic capabilities and new public health threats (2,
19, 20). For example, in 2001, when B. lonestari, an RF group
Borrelia species found in A. americanum, was tentatively linked to
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a case of southern tick-associated rash illness (STARI) (5),
HTTKP testing was modified to include testing for B. lonestari
(21–24). However, epidemiological studies of STARI patients did
not support the hypothesized link between STARI and B. lonestari
(6, 7, 25), so targeting of this Borrelia species in the HTTKP ended
in 2009. As a summary of our program from 1997 to 2010, a total
of 4,019 A. americanum adults, nymphs, and larvae were tested
with nested primers expected to amplify B. burgdorferi, and 7,421
were tested with primers that would have amplified all Borrelia
spp. (23). Although we initially reported that seven samples
(0.3%), all from 1997, produced amplicons (19), we believe con-
tamination was involved because all occurred within a short time
period in the first year of our study when we initially implemented
PCR techniques, and zero positive results were obtained across
large numbers of samples in all subsequent years. In contrast, over
the same period, a total of 5,458 Ixodes scapularis and 12 Ixodes
pacificus adults and nymphs were tested by the HTTKP using
equivalent assays: 24.7% of I. scapularis and 8.3% of I. pacificus
ticks tested positive for Lyme group Borrelia DNA. To summarize,
we found no measureable prevalence of B. burgdorferi in an epi-
demiologically relevant collection of A. americanum ticks from
across a broad geographic range over a 13-year period.
In 2013, however, debate about the role of A. americanum in
Lyme disease-like illness intensified, following a publication that
reported detection of B. burgdorferi DNA in two A. americanum
ticks removed from humans, and B. burgdorferi and B. andersonii
DNA in humans bitten by A. americanum (26). Given our exten-
sive background of PCR testing of A. americanum, and in view of
the novelty and potential clinical significance of the suggestion by
Clark et al. (26) that this tick species is contributing to unrecog-
nized cases of human borreliosis in the southeastern United
States, we used the primers and thermocycling protocol of Clark et
al. (26) in an attempt to detect Lyme group spirochetes in a large
sample (1,000) of A. americanum ticks removed from humans
throughout the eastern United States in 2013.
MATERIALS AND METHODS
Tick identification and DNA extraction. A. americanum ticks were re-
moved from military personnel and their families in the mid-Atlantic and
southeastern United States and submitted to the HTTKP (Table 1). Sub-
mitted ticks were identified to species morphologically. Genomic DNA
was then extracted either from individual ticks or from small pools of
conspecific ticks removed from the same human on the same date, using
a Zymo Genomic DNA II kit (Zymo Research Corporation, Orange, CA)
(27). Aliquots of DNA from five A. americanum samples were pooled for
a screening PCR; individual samples in these pools were archived for later
PCR and/or sequencing confirmation if the pool tested suspect positive.
Samples removed from the same person could contain more than one
tick, so some pools contained DNA from more than five ticks.
PCR and sequence analysis. At our USAPHC laboratory, nested PCR
for the flaB gene using primers from Clark et al. (26) was performed in
25-l reaction volumes prepared with Ready-To-Go PCR beads (Amer-
sham Pharmacia Biotech, Piscataway, NJ), containing 10 mM Tris-HCl
(pH 9.0), 1.5 mM MgCl2, 200 M each deoxynucleotide triphosphate
(dNTP), and 1.5 U Taq DNA polymerase. External reactions using outer
reaction primers 280F and 754R contained 2.5 l tick DNA (0.5 l from
individual ticks in pools of 5) and amplified a 475-bp product; internal
reactions using inner reaction primers 301F and 737R contained 1.0 l
external PCR and amplified a 437-bp product. Of the two internal reac-
tion primer sets published by Clark et al. (26), we used the set that pro-
vided the clearest gel results when tested with positive controls. This was
the primer combination—280F, 754R and 301F, 737R— used to amplify
Lyme group Borrelia in a subsequent study of human samples by Clark et
al. (28). Published thermal cycling parameters were followed (26, 28).
Three positive controls were used, consisting of B. burgdorferi strain B31
(a gift from R. Wirtz, CDC, Atlanta, GA) and two B. burgdorferi-positive I.
scapularis samples from the HTTKP. Each PCR included at least two neg-
ative controls, consisting of a water template sample that was introduced
at the time of DNA extraction and a water template sample that was
introduced at the time of PCR. Amplicons were visualized on 2% agarose
gel cassettes using ethidium bromide (E-Gel; Invitrogen Corp., Carlsbad,
CA). When a pool produced an amplicon at the 437-bp position, we then
tested DNA from the individual tick samples that comprised the pool to
ascertain individual-level infection, using the same method as described
above.
At our Texas A&M University (TAMU) laboratory, a blinded collec-
tion of flaB PCR-suspect-positive and -negative samples, along with pos-
itive and negative controls, was subjected to further analysis, following
whole-genome amplification to increase the amount of template DNA
available for testing (GenomiPhi; GE Healthcare, Pittsburgh, PA). This
amplification process produces a concentrated DNA template, and there-
fore DNA was diluted 1:25 for subsequent analyses. First, the identifica-
tion of tick species was confirmed through PCR and DNA sequencing of
the 12S rRNA gene (29). Next, a nested PCR for the 16S-23S rRNA inter-
genic spacer region (IGS) of Borrelia was performed, using primers and
thermal cycling parameters described previously (30). This assay amplifies
both RF and Lyme group borreliae, producing approximate 500-bp and
1,000-bp fragments, respectively. PCR amplicons from positive samples
were purified (ExoSAP-IT; Affymetrix, Santa Clara, CA) and bidirection-
ally sequenced. Sequences were manually edited, and the identification of
the Borrelia species was ascertained through comparison to sequences
published in NCBI GenBank. Finally, real-time quantitative PCR (qPCR)
was run on the samples using primers and probes for the 16S rRNA gene
of Borrelia, including a B. burgdorferi-specific probe and an RF group
probe (31).
At Ibis Biosciences, further testing of PCR-suspect-positive samples
was undertaken, using isothermal Borrelia enrichment performed as pre-
viously published (32). Enrichment of a negative control was also per-
formed. Following isothermal Borrelia DNA enrichment, a broad-range
TABLE 1 Origins by state of all ticks tested in this study
State No. of ticks tested
VA 661
MD 151
NJ 53
NC 48
KY/TNa 40
KY 33
KS 27
TN 24
MO 22
DE 14
SC 11
AL 4
AR 2
FL 2
GA 2
FL/GAb 1
RI 1
PA 1
Total 1,097
a Ticks from Ft. Campbell, on the border of Kentucky and Tennessee, are listed as
“KY/TN.”
b One tick was reported as acquired in either Florida or Georgia and is listed as
“FL/GA.”
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PCR followed by electrospray ionization mass spectrometry (IA/PCR/
ESI-MS) was performed, in which each sample was subjected to a series of
eight diagnostic PCRs (32, 33). By the selection of Borrelia PCR targets
that vary in sequence betweenBorrelia species and strains (genotypes), it is
possible to use the IA/PCR/ESI-MS technology to identify the Borrelia
species and distinguish its genotype even when present in mixtures of
genotypes (32, 33). A volume of 10l of isothermal amplified nucleic acid
extract was used in each PCR, and all PCRs were analyzed using an elec-
trospray ionization mass spectrometry system (Abbott Molecular, Des
Plaines, IL) as previously described (32, 33).
In silico analysis. Potential mispriming genomic loci were identified
for each primer assay of Clark et al. (26) using NCBI Primer-BLAST (http:
//www.ncbi.nlm.nih.gov/tools/primer-blast) default parameters against
the nr database (a nonredundant NCBI database that includes all Gen-
Bank, RefSeq Nucleotides, EMBL, DDBJ, and PDB sequences, excluding
HTGS0, 1, and 2, EST, GSS, STS, PAT, and WGS). The species of each
potential mispriming site was noted for each assay.
The flagellin sequences of experimentally identified potential cross-
reacting Borrelia species were aligned using Clustalw (http://www
.genome.jp/tools/clustalw/). The sequences used were from B. burgdorferi
B31 (NC_001318.1), B. andersonii (D83762.1), B. americana SCW-30 h
(HM802232.1), and B. lonestari MO2002-V1 (AY850063.1). The B. an-
dersonii, B. americana, and B. lonestari genomes are not yet fully assem-
bled, so the longest flagellin sequences deposited in NCBI Nucleotide were
chosen for the alignment.
The melting temperatures (Tms) for each primer assay were deter-
mined using an online calculator (http://www.idtdna.com/analyzer
/Applications/OligoAnalyzer/), adjusting default parameters to represent
our PCR conditions (0.8 M primers, 200 M dNTPs, and 1.5 mM
MgCl2) and identified mismatches.
Sensitivity test. PCRs were performed at USAPHC to compare the
sensitivity of the flaB primers from Clark et al. (26) and the set of nested
Borrelia genus fla primers from Barbour et al. (23) routinely used in the
HTTKP. Serial dilutions of B. americana SCW-30E, B. andersonii SI-10,
and B. bissettii FD-1 were tested with the two PCRs. These particular
strains are from the southern United States and were chosen in order to
more rigorously test the sensitivity of these primers and their ability to
detect all members of these species, because these strains varied the most
with the Barbour primers. To identify mismatches between the Barbour
fla primers and B. americana, B. andersonii, and B. bissettii strains from the
United States, an alignment of the flagellin sequences found in NCBI
GenBank was made using the MegAlign application in the DNAStar La-
sergene 12 software. The protocol for PCR using the Clark primers is
described above, and the PCR protocol for the Barbour primers is de-
scribed by Stromdahl et al. (3). Each test contained a positive control
containing B. burgdorferi strain B31 and a negative control consisting of a
water template sample that was introduced at the time of the PCR.
RESULTS
USAPHC testing. PCR using the nested flaB primers from Clark
et al. (26) was performed on 171 pools, comprising 1,097 individ-
ual A. americanum ticks. The geographic origin of these ticks is
listed in Table 1, and the results of testing are summarized in Table
2. The B31 positive controls and the two I. scapularis samples
previously PCR positive for B. burgdorferi all produced major
bands at 437 bp. In contrast, in most A. americanum samples, we
observed only a “ladder” effect (Fig. 1) that typically is indicative
of mispriming. For the few samples that produced a distinct major
band of the expected length (e.g., Fig. 1A, lane 7, and B, lane 8), we
classified the sample as suspect positive and investigated further.
Nine of 171 pools (5.3%)—P009, P084, P123, P171, P174, P189,
P191, P194, and P211—were selected by this criterion.
Additional testing was conducted on the individual samples
comprising the nine pools that produced major bands of the
437-bp size. Two of these pools (P009 and P171) yielded no sus-
pect-positive individual samples. Accordingly, we repeated the
flaB PCR on these and the remaining pools before testing the
individual samples from any more pools. The pools P009 and
P171, with no suspect-positive individual samples, and three ad-
ditional pools, P189, P191, and P211, were negative in the repeat
PCR of the pool, so the individual samples from P189, P191, and
P211 were not initially tested using the flaB primers. The five in-
dividual samples from P189 were later tested (see “Follow-up test-
ing at USAPHC and TAMU” below). Four pools (P084, P123,
P174, and P194) contained individual samples that produced a
437-bp amplicon. Three pools, P084, P123, P194, contained one
positive tick each, and one pool, P174, contained two positive
ticks. Overall, 5 of 1,097 (0.46%) individual A. americanum ticks
(130786, 131114, 131429, 131433, and 131566) produced major
bands of 437 bp. These five samples were submitted from Rhode
Island, Virginia, Tennessee, and New Jersey.
TAMU testing. The five individual samples (130786, 131114,
131429, 131433, and 131566) and eight pools (P009, P123, P171,
P174, P189, P191, P194, and P211) producing major bands of 437
bp in the flaB PCR were sent to the TAMU laboratory for further
analysis. The pool (P084) containing the individual suspect-pos-
itive sample from Rhode Island was not sent. The 12S rRNA se-
quence analysis revealed that all samples except one (130786 from
P084), contained DNA from A. americanum. Sample 130786, was
molecularly identified as I. scapularis and so had been misidenti-
fied by morphology at USAPHC as A. americanum. This tick sam-
ple, which had been removed from a human in Rhode Island, was
retained as a positive control in subsequent analyses and was con-
firmed as positive for B. burgdorferi in all subsequent assays.
In the IGS PCR, six of eight pools (P123, P171, P174, P189,
P194, and P211) produced amplicons, including five amplicons
(P123, P171, P174, P194, and P211) that were approximately 500
bp (indicative of RF group spirochetes) and one very faint ampli-
con (P189) that was approximately 1,000 bp (indicative of Lyme
group spirochetes) (Table 2). Additionally, all four individual A.
americanum ticks (131114, 131429, 131433, and 131566) pro-
duced amplicons approximately 500 bp in size, and all four were
associated with pools producing amplicons approximately 500 bp
in size. DNA sequencing of these 500-bp IGS amplicons in each
case revealed the presence of B. lonestari (Table 2). The sequence
reaction failed for the faint 1,000-bp IGS amplicon from pool
P189.
In the qPCR, six (P123, P171, P174, P189, P194, and P211) of
eight pools were considered suspect positive. Consistent with the
IGS results reported above, five pools (P123, P171, P174, P194,
and P211) were positive with the RF group probe (CT values
ranged from 32 to 35), and one (P189) was weakly positive with
the Lyme group Borrelia probe (CT value of 39) (Table 2). Addi-
tionally, all four individual A. americanum ticks (131114, 131429.
131433, and 131566) were positive with the RF group probe (CT
values ranged from 31 to 33), consistent with the IGS results that
indicated the presence of B. lonestari DNA in these samples.
IA/PCR/ESI-MS analysis. Nine pools (P009, P084, P123,
P171, P174, P189, P191, P194, and P211) and four individual
samples (131114, 131429, 131433, and 131566) producing a major
band of 437 bp in the flaB PCR assay and four pools (P184, P187,
P20, and P211) and five individual samples (131431, 131559,
131560, 131570, and 131571) that were negative in that assay were
B. burgdorferi Not Confirmed in A. americanum
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sent blinded from USAPHC to Ibis Biosciences for analysis using
the IA/PCR/ESI-MS assay.
The two pools (P009 and P191) that were negative in all TAMU
assays were also negative in the Ibis assay. The four previously
Borrelia-negative pools (P184, P187, P220, and P221) and two
(131431 and 131570) of the five Borrelia-negative individual sam-
ples sent as controls were also negative using the Ibis assay. Three
of the individual samples (131559, 131560, and 131571) deter-
mined to be negative at USAPHC produced weak positives for B.
lonestari in analysis at Ibis Biosciences (Table 2). All five pools
(P123, P171, P174, P194, and P211) and four individual samples
(131114, 131429, 131433, and 131566) identified as containing B.
lonestari at TAMU were also positive for this organism at Ibis
Biosciences. Pool P189, which was suspect positive for B. burgdor-
feri in two assays at TAMU was also positive for B. burgdorferi in
the Ibis assay using their IA/PCR/ESI-MS assay, but for only three
of eight primers: BCT 3515 (rplB gene), BCT 3517 (flagellin gene),
and BCT 3519 (hbb gene). The pool (P084) containing the B.
burgdorferi-positive I. scapularis tick molecularly identified at
TAMU was positive for B. burgdorferi as well as B. lonestari at Ibis
Biosciences.
Follow-up testing at USAPHC and TAMU. In order to thor-
oughly investigate P189, the DNA of the five ticks (131535,
131536, 131537, 131538, and 151359) that comprised this pool
was analyzed individually both at USAPHC and at TAMU. Two
nested PCRs for Borrelia were used at USPAHC: the flaB assay
from Clark et al. (26) and the Borrelia genus fla PCR from Barbour
et al. (23). In the former assay, all of the individual samples from
P189 produced multiple faint bands (laddering) and none had a
437-bp major band; all were scored as negative. Similarly, all sam-
TABLE 2 Analysis of A. americanuma samples with bright bands at 437 bp in the B. burgdorferi flaB PCR of Clark et al. (26)b
Pool
PCR sample
no. in poolc
Result from:
Result from follow-up testing of samples
in P189
USAPHC
flaB PCRd TAMU
Ibis Borrelia genotyping
(no. of primers
Pos/total)g
USAPHC TAMU
1st 2nd Borrelia qPCRe
IGS PCR
(bp)f
IGS
sequencing
flaB
PCRd
fla
PCRh
flaB
PCRd
flaB
sequencing
P009 Pos Neg Neg Neg ND Neg ND ND ND ND
P084a Pos ND ND ND ND B. burgdorferi, 5/8; B.
lonestari var. 1, 3/5
ND ND ND ND
130786a Pos ND ND 1,000 ND ND ND ND ND ND
P123 Pos ND RF 500 ND B. lonestari var. 1, 3/5 ND ND ND ND
131114 Pos ND RF 500 B. lonestari B. lonestari var. 1, 5/5 ND ND ND ND
P171 Pos Neg RF 500 B. lonestari B. lonestari var. 1, 4/5 ND ND ND ND
P174 Pos Pos RF 500 ND B. lonestari, 4/5; B.
lonestari var. 1, 4/5
ND ND ND ND
131429 Pos ND RF 500 B. lonestari B. lonestari, 5/5; B.
lonestari var. 1, 5/5
ND ND ND ND
131433 Pos ND RF 500 B. lonestari B. lonestari var. 1, 5/5 ND ND ND ND
P189 Pos Neg B. burgdorferi
(very high CT)
1,000
(faint)
Failed B. burgdorferi, 3/8 ND ND ND ND
131536 ND ND ND ND ND ND Neg Neg Pos (very
faint)
Failed
P191 Pos Neg Neg Neg ND Neg ND ND ND ND
P194 Pos Pos RF 500 ND B. lonestari, 5/5 ND ND ND ND
131559 Neg ND ND ND ND B. lonestari, 1/5 ND ND ND ND
131560 Neg ND ND ND ND B. lonestari, 2/5 ND ND ND ND
131566 Pos ND RF 500 B. lonestari B. lonestari, 5/5 ND ND ND ND
131571 Neg ND ND ND ND B. lonestari, 1/5 ND ND ND ND
P211 Pos Neg RF 500 B. lonestari B. lonestari, 5/5 ND ND ND ND
a Sample 130786 in P084 had been initially misidentified as A. americanum at USAPHC and was later molecularly identified as I. scapularis at TAMU.
b USAPHC, U.S. Army Public Health Command; TAMU, Texas A&M University; Ibis, Ibis Biosciences; Pos, positive; Neg, negative; ND, not determined.
c PCR-negative samples not shown.
d flaB PCR for B. burgdorferi sensu lato (26).
e 16S rRNA qPCR for Borrelia spp. (31). CT, cycle threshold; RF, relapsing fever group Borrelia.
f 16S-23S rRNA intergenic spacer region (IGS) PCR for Borrelia spp. (30).
g PCR, electrospray ionization mass spectrometry (IA/PCR/ESI-MS) for Borrelia (32, 33); var., variant.
h fla PCR for Borrelia spp. (23).
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ples were negative in the generic fla assay. Using the same flaB
assay from Clark et al. (26) at the TAMU laboratory, we also ob-
tained a laddering effect in most samples on the gel, indicative of
mispriming. One sample (131536) produced a faint band at the
diagnostic 437-bp size (in addition to at least one smaller fragment
band of the same intensity). Attempts to obtain a DNA sequence
from this sample using a direct approach as well as after excising
the 437-bp band from the gel were not successful, and the sample
was therefore scored as negative.
In silico analysis of the nested-PCR assay. NCBI Primer-
BLAST analysis of the nested-PCR assay from Clark et al. (26)
indicated that the flagellin genes from multiple Borrelia species
could be amplified. For the external reaction, a 475-bp amplicon is
expected. The BLAST results yielded amplicons of 445 to 475 bp
that corresponded to 19 Borrelia species, including the experi-
mentally identified species B. burgdorferi, B. andersonii, B. ameri-
cana, andB. lonestari. For the internal reaction, a 437-bp amplicon
is expected. The BLAST results yielded amplicons of 407 to 440 bp.
All 19 species identified by the external reaction are also potential
mispriming loci with the internal reaction.
A more detailed in silico analysis was performed comparing the
flaB gene from B. burgdorferi to those of the three experimentally
identified cross-reacting Borrelia species. The external and inter-
nal primers were also aligned to the sequences. The external
primer assay revealed a perfect match to B. burgdorferi and B.
andersonii (due to the degenerate base) and a single mismatch to
B. americana. The external reaction has multiple mismatches to
the B. lonestari sequence, most importantly a mismatch at the
3=-terminal nucleotide in the reverse primer and a mismatch 3 bp
from the 3= terminus of the forward primer. The internal reaction
has a perfect match with B. burgdorferi, B. andersonii, and B. amer-
icana. This reaction has four mismatches between the internal
reverse primer and the B. lonestari sequence, including two close
to the 3= end of the primer.
Sensitivity test. The MegAlign comparison of the flagellin se-
quences found in NCBI GenBank revealed that all four of the
Clark primers were an exact match to B. americana SCW-30E.
Three of the primers (301F, 737R, and 745R) were 100% matches
to B. andersonii SI-10 and B. bissettii FD-1, although with the 301F
primer, only 21/23 bases of the primer could be determined. The
match of the 280F primer to B. andersonii SI-10 and B. bissettii
FD-1 could not be determined as the sequences are unknown;
however, the 280F primer was an exact match to all of the U.S.
sequences of B. bissettii (DN127) and B. andersonii (19857, 21038,
and 21123) that were available in NCBI GenBank.
The B. americana SCW-30E flagellin sequence was a 100% (24/
24) match with the Barbour FlaLL primer and a 95% (21/22)
match with FlaLS; its matches with FlaRS and FlaRL could not be
determined. However, the FlaRS primer was a 100% match (26/
26) with the one U.S. sequence of B. americana (SCW-30 h) that
was available in NCBI GenBank. The B. andersonii SI-10 flagellin
sequence was a 100% match (22/22) with the Barbour FlaLL
primer over the 22/24 bases it could be aligned with, an 86% (19/
22) match with FlaLS, a 96% (25/26) match with FlaRS, and a 92%
(11/12) match with FlaRL over the 11/24 bases it could be aligned
with. The B. bissettii FD-1 flagellin sequence was a 100% match
(22/22) with the Barbour FlaLL primer over the 22/24 bases it
could be aligned with, a 100% (22/22) match with FlaLS, and a
92% (24/26) match with FlaRS, and its match with FlaRL could
not be determined. However, the FlaRL primer was a 96% match
(23/24) with the one U.S. sequence of B. bissettii (DN127) that was
available in NCBI GenBank.
In the PCR comparison, the flaB primers from Clark (26) and
the fla primers from Barbour et al. (23) produced identical results
in amplifying increasingly dilute amounts of the three Lyme group
spirochetes. The analytical sensitivity (limit of detection [LOD])
of both primer sets in amplifying B. americana DNA was deter-
mined to be 0.3 copy/l (1:10 M dilution). The LOD of both
primer sets in detecting B. andersonii DNA was7 copies (1:1 M
dilution), and the LOD of both primer sets in detecting B. ander-
sonii DNA was6 copies (1:1 M dilution).
DISCUSSION
We were unable to confirm any Lyme group Borrelia infection in a
detailed investigation of 1,097 A. americanum ticks removed from
humans in the southeastern and mid-Atlantic United States.
FIG 1 Agarose gels after nested PCR to amplify the Borrelia flaB gene (26) in Amblyomma americanum ticks. Nonspecific binding was present in all tick samples
but absent in the negative-control lane (no. 2) and the B. burgdorferi B31 positive-control lane (no. 12). Only samples with bright bands at 437 bp were considered
suspect positive in our study. (A) Lanes 3 to 11 correspond to pooled samples of ticks. (B) Lanes 3 to 8 correspond to individual tick samples from previously
tested pools, and lanes 9 to 11 are retests of pooled samples. Pooled sample P123 (gel A, lane 7) and individual sample 131114 from P123 (gel B, lane 8) were
confirmed to be infected with B. lonestari by PCR and sequencing of the IGS PCR product and by IA/PCR/ESI-MS (Table 2).
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Other recent investigations have similarly failed to reveal B. burg-
dorferi inA. americanum. NoB. burgdorferiwas detected during an
extensive molecular characterization of the microbiome of 732 A.
americanum adults and nymphs collected in Texas and Missouri
(34), and a study of 3,000 A. americanum ticks from Georgia
using PCR with fla primers from Barbour et al. (23) reported
detection only of B. lonestari (35). The Barbour primers are de-
signed to amplify all Borrelia spp., and analytical sensitivity testing
of these primers in this study has indicated that they can detect the
strains of B. americana, B. andersonii, and B. bissettii that have the
most mismatches with these primers, suggesting that they can
detect all members of each of these species.
Clark et al. (26) have suggested that A. americanum ticks are a
significant source of viable B. burgdorferi (sensu lato or sensu
stricto). In our hands, however, the flaB nested-PCR assay upon
which that suggestion was based produced many faint nonspecific
bands, likely indicative of mispriming by amplification of DNA
from the tick, human DNA in the tick blood meal, or other organ-
isms in the tick midgut microbiome. Amplification was also in-
consistent since samples with major 437-bp bands failed to pro-
duce amplicons in repeat testing. Similar inconsistent results (i.e.,
negative when previously suspect positive or with inconsistent
band sizes and numbers) have been reported in another trial of the
Clark et al. flaB assay using I. scapularis ticks (36); in that study, as
in ours, sequencing attempts of the PCR products of the unknown
tick samples failed. This stochastic fluctuation in PCR outcome
may be attributable to the low annealing temperature and/or the
high primer concentration. The Clark assay utilizes an annealing
temperature of 52°C for the external reaction and 55°C for the
internal reaction (26). The optimal annealing temperature in a
PCR should be determined empirically, but it must be below the
melting temperature (Tm) of the oligonucleotide primers. Results
of analysis using the Tm calculator indicate that the Tm for range
for the flaB primers (26) is 60 to 62°C. However, primer mis-
matches to the DNA template, such as to the B. lonestari flagellin
gene, reduce primer Tm. Including the B. lonestari mismatches in
the Tm calculator resulted in a Tm range of 57 to 64°C. (The Tm for
some primers increased due to an increase in GC percentage once
A/T mismatches were removed.) The same analysis could be used
for all other potential cross-reacting nontarget species, which may
explain the laddering effect of this nested assay. We did not take
steps to optimize the PCR primers or protocols described by Clark
et al. because our aim was to closely replicate the conditions by
which B. burgdorferi DNA was reported as being detected in that
study. Although these flaB primers were described as being spe-
cific for Lyme group Borrelia spp., we used an independent PCR
for a different genetic region (30) to amplify and sequence B.
lonestari from samples that appeared to be suspect positive in the
flaB assay (26).
Nucleotide mismatches at the 3= terminus of a primer signifi-
cantly reduce polymerase extension. However, a low level of poly-
merase readthrough can still occur (37), and because PCR results
in exponential amplification of a template, even a low level of
readthrough can become significant after sufficient PCR cycles.
The ability of the Clark primers to amplify B. andersonii and B.
americana has already been experimentally identified (26, 28), but
the B. lonestari result is unexpected. We hypothesize that PCR
readthrough from the external reaction explains both the B. lone-
stari positive results, and the lack of repeat positive results. If the
readthrough occurs during the first cycles of the external reaction,
then sufficient amplicon is produced to have a high rate of ampli-
fication in the internal reaction, resulting in a major band of the
expected size. The internal reaction should amplify B. lonestari
sequences from the external reaction, since the forward internal
primer has an exact match to B. lonestari sequence, and the reverse
primer only shows mismatches at the 5= end of the primer, which
will not affect amplification. However, if readthrough does not
occur until a later cycle of the external reaction, insufficient am-
plicons are produced, resulting in a negative reaction.
Although readthrough and mispriming occur, we would not
expect this to be a common event. Therefore, we examined the
PCR methods as an additional explanation. The readthrough and
mispriming likelihood may have been increased due to the high
concentration of primers and low annealing temperature specified
by Clark et al. This analysis reveals that the low annealing temper-
atures of the Clark assay are not very stringent, increasing the
probability of mispriming resulting in amplification of B. lonestari
and other nonspecific targets. This mispriming has the result of
decreasing the sensitivity of these primers so that a higher target
copy number is required for amplification to occur. Although
Clark et al. performed a BLAST analysis (26), the analysis would
not have identified many of the 19 identified potential cross-re-
actingBorrelia species if they used the reference genome data set or
only BLASTed against selected GenBank files. Many Borrelia ge-
nomes (including B. lonestari) are not yet fully sequenced. Al-
though we chose the longest deposited B. lonestari flagellin se-
quence for the alignment to B. burgdorferi, we did an additional
alignment with 109 B. lonestari flagellin sequences deposited in
NCBI Nucleotide (data not shown). Only three records included
the outer forward reaction, but five included the inner forward
reaction, all of which showed sequence identity. All 109 records
included the inner reverse reaction, and 107 records included the
outer reverse reaction. Of these alignments, only two did not have
sequence identity. This alignment confirmed the accuracy of the
sequence we used for the original alignment.
As explained above, the assay from Clark et al. (26) would not
be expected to consistently amplify B. lonestari; therefore, some B.
lonestari-positive A. americanum samples might have been missed
in the initial screen at USAPHC using only the Clark primers.
Testing at TAMU and Ibis Biosciences using assays designed to
amplify B. lonestari detected this organism in samples that had
produced negative or inconsistent results using the Clark primers
at USAPHC (Table 2). However, the low prevalence of infection
with B. lonestari detected in these samples is congruent with pre-
vious surveillance (2, 8, 21, 24, 34, 35). For example, in our pro-
gram from 1997 to 2010, a total of 18,546 A. americanum ticks
were tested with nested and real-time primers that were capable of
amplifying B. lonestari, and 195/17,226 (1.1%) of adults and
nymphs and 4/1,320 larvae (0.3% minimum infection prevalence)
were positive (2, 8, 20).
Ibis Biosciences reported low-level detection of B. burgdorferi
DNA in a pooled sample of A. americanum DNA (sample P189) by
three of the eight primer pairs capable of detecting B. burgdorferi.
This pool had also been weakly positive for B. burgdorferi in the
two assays at TAMU. The PCR signal was very different from that
provided by B. burgdorferi-infected I. scapularis ticks; further-
more, B. burgdorferi sequences were not detected in any of the
individual samples in the pool. We suggest the weak result in our
assays may reflect low-level contamination of P189, possibly in-
troduced at the DNA isolation and pool-forming step, or the am-
Stromdahl et al.
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plification of the remnants of an infected blood meal from a pre-
vious life stage. All five samples in this pool were single ticks from
Ft. Pickett, VA; two were nymphs, two were females, one was a
male, and all were unengorged and removed from humans. A few
B. burgdorferi-infected I. scapularis ticks have been submitted to
the HTTKP from Ft. Pickett, demonstrating that the pathogen is
indeed circulating in that environment (E. Stromdahl, unpub-
lished data). Other Lyme group Borrelia species, B. americana, B.
andersonii, B. bissetti, etc., were not detected.
To summarize, we were unable to confirm any Lyme group
Borrelia infection in A. americanum ticks removed from humans
in the southeastern and mid-Atlantic United States. In our inves-
tigation, we utilized the flaB primers and thermal cycling param-
eters of Clark et al. because this diagnostic tool was associated with
the reported finding of Lyme group Borrelia DNA in a small num-
ber of A. americanum ticks and blood samples from humans re-
ported to have been fed upon by A. americanum (26). In our in-
vestigation, this flaB assay produced indistinct and inconsistent
results in A. americanum ticks, and the samples that produced
major bands at the expected fragment size were confirmed to be
positive for B. lonestari DNA (but not Lyme group Borrelia DNA)
in multiple different assays. In agreement with decades of previous
research, we therefore conclude that human-biting A. america-
num ticks are not a vector of B. burgdorferi. The conclusion of
Clark et al. that A. americanum is infected with Lyme group Bor-
relia spp. is based on the detection of flaB gene sequences alone.
Given that this finding is in striking contrast to decades of previ-
ous investigations of the topic, a more rigorous approach would
have been to more fully characterize the organism through the
amplification and sequencing of multiple genes or verification by
culturing of the organism, to provide more convincing evidence of
identification (38). Conclusions based on inadequate evidence ex-
acerbate public confusion: findings of Borrelia spp. in novel tick
species should in future always be supported by characterization
of multiple gene targets.
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Erratum for Stromdahl et al., Borrelia burgdorferi Not Confirmed in
Human-Biting Amblyomma americanum Ticks from the Southeastern
United States
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Volume 53, no. 5, p. 1697–1704, 2015. Page 1698, column 1, lines 10–11: “Although we initially reported that seven samples (0.3%), all
from 1997, produced amplicons (19), we believe . . .” should read “Although we initially reported that seven samples (7/222 3.2%),
all from 1997, produced amplicons in PCRs for two different gene targets (19), we believe . . . .”
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